Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Allogene Therapeutics Inc | 22,032,040 | 22,032,040 | 0 | $49.79M | $46.93M | 27.55% | -$2.86M |
| Celcuity Inc.(CELC) | 295,652 | 295,652 | 0 | $31.35M | $29.55M | 17.35% | -$1.79M |
| Arvinas, Inc.(ARVN) | 3,457,815 | 3,457,815 | 0 | $34.92M | $27.66M | 16.24% | -$7.26M |
| Pyxis Oncology, Inc.(PYXS) | 7,032,770 | 7,032,770 | 0 | $9.21M | $19.48M | 11.43% | +$10.27M |
| Wave Life Sciences, Inc.SHS(WVE) | 1,875,000 | 1,875,000 | 0 | $11.93M | $10.93M | 6.42% | -$1.00M |
| Biohaven Ltd.(BHVN) | 505,645 | 505,645 | 0 | $4.23M | $8.00M | 4.70% | +$3.77M |
| Caribou Biosciences, Inc.(CRBU) | 4,690,431 | 4,690,431 | 0 | $8.35M | $7.88M | 4.63% | -$469.0K |
| Spero Therapeutics, Inc.(SPRO) | 2,362,348 | 2,362,348 | 0 | $5.50M | $5.34M | 3.13% | -$165.4K |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 953,834 | 953,834 | 0 | $2.00M | $3.85M | 2.26% | +$1.85M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 4,780,401 | 372,904 | -4,407,497 | $57.65M | $3.55M | 2.09% | -$54.10M |
| Cardiff Oncology, Inc.(CRDF) | 2,411,575 | 2,411,575 | 0 | $3.74M | $3.01M | 1.77% | -$723.5K |
| Zura Bio LimitedCL A(ZURA) | 2,838,913 | 538,841 | -2,300,072 | $16.83M | $2.88M | 1.69% | -$13.95M |
| AgomAb Therapeutics NVADS(AGMB) | 75,000 | 75,000 | 0 | $813.8K | $1.04M | 0.61% | +$222.0K |
| Bolt Biotherapeutics Inc | 31,305 | 31,305 | 0 | $137.1K | $133.8K | 0.08% | -$3.3K |
| Nextcure Inc | 153,354 | 44,347 | -109,007 | $1.54M | $73.0K | 0.04% | -$1.46M |
| Ginkgo Bioworks Holdings, Inc.CL A(DNA) | 2,928 | 2,928 | 0 | $17.4K | $30.0K | 0.02% | +$12.6K |
| Senseonics Holdings, Inc.(SENS) | 2,171 | 2,171 | 0 | $14.2K | $12.4K | 0.01% | -$1.8K |
| Q32 Bio Inc.(QTTB) | 101,618 | 0 | -101,618 | $736.7K | $0 | — | -$736.7K |